Source of infection affects hospital mortality in septic shock patients in the ICU
In ICU patients who have septic shock, the anatomic source of infection has a strong effect on the chances of survival, according to a new study from researchers in Canada.
Diseases, Conditions, Syndromes
May 20, 2013 |
not rated yet |
0
Long-term outcomes in patients with advanced coronary artery disease are better than expected
Death rates associated with patients with refractory angina, or chronic chest pain, are lower than previously considered; therefore, physicians should focus on relieving the chest pain symptoms and improving the quality of ...
Cardiology
May 15, 2013 |
not rated yet |
0
With suspected TB, behavioral support curbs smoking
(HealthDay)—Behavioral support with or without bupropion is effective at achieving smoking cessation in patients with suspected tuberculosis, according to a study published in the May 7 issue of the Annals of ...
Health
May 11, 2013 |
not rated yet |
0
New antiviral treatment could significantly reduce global burden of hepatitis C
(Medical Xpress)—Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and ...
Diseases, Conditions, Syndromes
May 06, 2013 |
not rated yet |
0
CLABSI prevention efforts result in up to 200,000 infections prevented in intensive care units
New research from the Centers for Disease Control and Prevention (CDC) estimates that as many as 200,000 central line-associated bloodstream infections (CLABSIs) have been prevented among patients in intensive care units ...
Diseases, Conditions, Syndromes
May 13, 2013 |
not rated yet |
0
World Malaria Day: Research into a more efficient treatment for 'vivax malaria'
Whilst investment has been increasing in the past years into new treatments for the potentially fatal "malaria tropica", efficient treatment options are still lacking for "vivax malaria". This is a form of ...
Diseases, Conditions, Syndromes
Apr 29, 2013 |
not rated yet |
0
Research spinoff ReXceptor gets license for Alzheimer's treatment
Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical ...
Alzheimer's disease & dementia
Apr 25, 2013 |
4 / 5 (1) |
0
